Illumina has announced the development of an advanced spatial transcriptomics technology, with commercial availability expected in 2026. This next-generation solution is designed to enhance ...
At AGBT, customers will present data demonstrating unparalleled scale and sensitivity in research spanning pulmonary fibrosis, prostate cancer, and 3D reconstructions of mouse brains Company expands ...
Conventional transcriptomic techniques have revealed much about gene expression at the population and single-cell level—but they overlook one crucial factor: spatial context. In musculoskeletal ...
Identifying and characterizing the multitude of cell types that make up the brain is fundamental to understanding their function in health and disease. Single-cell RNA sequencing (scRNA-seq) ...
Certain cells in the brain create a nurturing environment, enhancing the health and resilience of their neighbors, while others promote stress and damage. Using spatial transcriptomics and AI, ...
Illumina is raising the curtain on its upcoming entry into spatial transcriptomics, with tech designed to help researchers explore cellular behavior mapped across complex tissues. The announcement ...
Hosted on MSN
What Is Spatial Transcriptomics?
Spatial transcriptomics is a technique that provides information about gene expression patterns within intact tissues. This technology employs various methodologies, including in situ sequencing (ISS) ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback